In sickle cell disease we have almost the whole story, from the mutant DNA base representing the essential genetic change to the mode of clinical presentation. Thus to demonstrate a simple pattern of inheritance is to imply a relatively simple biochemical pathway and ultimate etiological clarification. However, most common diseases, including many congenital malformations and the so-called degenerative disorders, are multifactorially determined, implying the participation of a number of environmental factors and 'polygenes'. It is thought that individuals have more or less liability to diseases of this type but only develop clinical manifestations when their liability oversteps a threshold. Liability is made up of genetic predisposition and a number of (usually unknown) etiological agents in the environment and it is convenient to consider the distribution of liability towards a given disease in the population as being normally distributed.
The characteristic feature of diseases which are multifactorially determined is that the risk to children is more or less the same as for siblings and the risk to second-degree and more distant relatives falls off sharply. This is in contrast to autosomal recessive inheritance where, excluding consanguineous and chance mating to a heterozygous carrier, the risk is virtually confined to the siblings of the proband.
Genetic counselling involving diseases of multifactorial origin must be based upon empirical risk figures derived from data obtained in surveys of families in which the same disease occurs. When dealing with autosomal recessive disease the risk to each sibling is 1:4.
Eugenic considerations have little place in multifactorial and recessive conditions. For example: the common form of retinitis pigmentosa with or without deafness is inherited as an autosomal recessive. The frequency of affected individuals is something like 1 in 20,000 -not particularly common. Affected individuals are usually fertile and it is often asked if they should avoid the risk of passing on the gene. Unrecognized heterozygotes occur with a frequency of about 1 in 70 in the population (i.e. 300 times as often as cases of the disease) and it can be seen that whether or not individuals with the disease pass on the gene is numerically unimportant. Counselling should thus be based upon the risk that each offspring will have the disease (about 1 in 140 for nonconsanguineous matings), the prognosis and the likely future ability of the parent to cope with and provide for the children.
Autosomal dominant conditions of sufficient severity to require counselling are of course relatively rare. The genetic problem is apparently simple and on average half the offspring of affected individuals will inherit the mutant allele. It is, however, now obvious that phenotypically similar diseases may have quite different modes of genetic determination (genetic heterogeneity), while in some cases the disease may not be genetic in origin (phenocopy). Delay in expression of a mutant gene (e.g. Huntington's chorea), great variation in its expression (e.g. von Recklinghausen's disease) and new mutants (e.g. achondroplasia) combined with genetic heterogeneity and the existence of phenocopies, serve to complicate greatly the task of the genetic counsellor in dealing with autosomal dominant diseases.
Many similar problems arise with X-linked recessive traits. Because of small family size it is often difficult to decide whether or not an isolated case of Duchenne muscular dystrophy represents a new mutation with little risk to other members of the family. Enzyme estimations performed on the mother's serum will greatly help since it may be possible, if these tests are negative, to be 80 % certain that the child is carrying a new mutation.
Genetic counselling is thus primarily dependent upon precise diagnosis and upon accurate pedigree. New techniques for antenatal diagnosis of chromosomal anomalies and biochemical disorders and an increased ability to recognize carriers of recessive genes greatly improve the quality of genetic diagnosis.
In counselling, simple statements of risk are rarely sufficient. Clinical acumen is required to perceive the unspoken fears and feelings of guilt which are usually associated with inherited disease (sometimes confused by patients with venereal disease).
When there is a high risk of producing affected offspring patients often ask for specific advice. Although it is tempting to consider the problem in relatively eugenic terms, attempts to eliminate apparently deleterious genes from the human population, even if this were possible, must be regarded with suspicion. For example, the sickle cell gene, although nearly lethal in homozygotes, actually protects infants in areas where falciparum malaria is common. Such genes represent a part of the essential genetic variability which organisms need if they are to be equipped to resist environmental stress. The mortality of brain abscesses has improved little since Sir William MacEwen moved triumphantly into the field ninety years ago. The validity of his figures has been questioned, but there are detailed records of the cure of patients in such deep coma that operation was performed without aneesthesia; this was attained by the logical eradication of infection from mastoid and petrous bones through the dura mater to the brain abscess.
Later neurosurgical techniques aided by sophisticated methods of diagnosis solved some problems but created othersnotably a division between the neurosurgeon and the otologist. Mortality remained high, delayed diagnosis, failure to find the abscess or to locate an additional subdural or second abscess on the other side of the tentorium causing fatalities. In the cases coming to autopsy in Marnchester, the track of infection from bone to brain was apparent in all cases, notably where a second abscess had been missed.
Experience with petrosectomy for intractable petrositis (to be published) encouraged the treatment of infection as an entity from the outset; not from the ear, but by exposing in one operation the middle and posterior fossm and the cranial surface of the petrous bone. The diseased bone is removed and pathways of infection are followed to brain abscesses which are tapped or removed. In fact the full otological procedure may be accomplished from above at the initial operation. Even where there is only a suspicion of brain abscess this may well be the logical approach to the infected ear.
Short-term Intensive Corticotrophin Treatment in Myasthenia Gravis [Abstract]
by L A Liversedge MD FRCP (University Department ofNeurology, Royal Infirmary, Manchester, M13 9 WL) A number of articles have appeared in the past, dealing with the possible therapeutic benefit to be derived from the use of steroids and corticotrophin preparations in the management of myasthenia gravis. Almost all observers have commented on the fact that during treatment patients have tended to become worse, and indeed it has been suggested that during intensive courses of corticotrophin the patient should be in a respiratory unit lest any disaster occur.
The modes of treatment have varied considerably and consequently the results have also been variable. We became interested in the possible explanation of the deterioration which takes place, and over the past three years have treated a series of patients with corticotrophin, studying their electrolytes before, during and after treatment.
The striking features are the reduction in sodium excretion and the relative increase in potassium excretion which accompanies this form of treatment. We found that, provided sodium intake was restricted, there was no serious deterioration in the patient's condition during treatment.
Seventeen patients were treated and at the time of presentation had been followed for periods ranging from 8 months to 3 years. Twelve were improved, 5 were considered unchanged and none were made worse. The degrees of improvement were graded: excellent, 5; very good, 4; appreciable, 3. The 5 patients not helped included 2 late resistant cases, 2 rapidly generalized and 1 moderately generalized. The 12 improved patients comprised all types except the late resistant. The duration of the disease prior to the course of treatment seemed to make little difference to the probability of improvement. The duration of benefit ranged from 6 months to 3 years (and continuing).
[This work will be published more fully elsewhere.] Air Meatography in Investigation of Cerebellopontine Angle Tumours [Abstract] by Ian Isherwood MB FFR (Manchester Royal Infirmary, Oxford Road, Manchester, M13 9 WL) A radiological approach to the cerebellopontine angle employing small quantities of air and linear tomographic techniques was described.
The value of this procedure in the demonstration of the normal angle including the VIII nerve was discussed together with the assessment of some pathological processes which may affect it.
The following papers were also read: 
